IP Library Granted Patent US 12,521,349
Granted Patent B2
US 12,521,349 · App. 17/606,757 · Granted Jan 13, 2026

Initial burst release controlled depot composition and a method thereof

Inventors: Duck Soo Lim (Suwon-si, KR); Eun Joo Lee (Hwaseong-si, KR)
Assignee: TIONLAB THERAPEUTICS
A61K9/1694A61K9/1617A61K9/1647A61K38/26
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,521,349
App. No.
17/606,757
Filed
Oct 26, 2021
Granted
Jan 13, 2026
Kind
B2
Art Unit
1627
USPC
514/772.7
Abstract

A depot composition including a hydrophobic amino acid in a microsphere is provided. The depot composition is capable of controlling the initial burst release of an excess amount of the active ingredient in a formulation including a biodegradable polymer and an active ingredient. The depot composition has excellent suspending ability, and is able to uniformly and continuously obtain the effect of the active ingredient even when an ordinary user uses the composition as a formulation for injection.

Claims (8)

1 . A depot composition comprising microspheres comprising an oil layer (O layer) comprising a biodegradable polymer and a hydrophobic amino acid,

wherein the microspheres comprise a hydrophobic amino acid in an amount of less than 1.5 parts by weight in an oil phase solution, based on 100 parts by weight of the biodegradable polymer.

2 . The depot composition of claim 1 , wherein the microspheres further comprise a hydrophobic amino acid in a water phase layer.

3 . The depot composition of claim 1 , wherein the microspheres have a bulk density (BD) of 0.1 g/ml or more and a zeta-potential between −8 mV and −30 mV.

4 . The depot composition of claim 1 , wherein the hydrophobic amino acid is selected from the group consisting of valine, methionine, alanine, phenylalanine, tryptophan, isoleucine and leucine.

5 . The depot composition of claim 2 , wherein the microspheres comprise a hydrophobic amino acid in an amount of 0.05% (w/v) to 25% (w), based on the entire water phase solution.

6 . The depot composition of claim 1 , wherein the biodegradable polymer is a polymer comprising lactide and glycolide as monomers.

7 . The depot composition of claim 6 , wherein the biodegradable polymer has an inherent viscosity (25° C.) of 0.35 to 0.65 dL/g.